J Clin Neurol.  2016 Jan;12(1):21-33. 10.3988/jcn.2016.12.1.21.

Acute Symptomatic Seizures Caused by Electrolyte Disturbances

• Nardone R
• Brigo F
• Trinka E

• KMID: 2364916
• DOI: http://doi.org/10.3988/jcn.2016.12.1.21

Abstract

In this narrative review we focus on acute symptomatic seizures occurring in subjects with electrolyte disturbances. Quite surprisingly, despite its clinical relevance, this issue has received very little attention in the scientific literature. Electrolyte abnormalities are commonly encountered in clinical daily practice, and their diagnosis relies on routine laboratory findings. Acute and severe electrolyte imbalances can manifest with seizures, which may be the sole presenting symptom. Seizures are more frequently observed in patients with sodium disorders (especially hyponatremia), hypocalcemia, and hypomagnesemia. They do not entail a diagnosis of epilepsy, but are classified as acute symptomatic seizures. EEG has little specificity in differentiating between various electrolyte disturbances. The prominent EEG feature is slowing of the normal background activity, although other EEG findings, including various epileptiform abnormalities may occur. An accurate and prompt diagnosis should be established for a successful management of seizures, as rapid identification and correction of the underlying electrolyte disturbance (rather than an antiepileptic treatment) are of crucial importance in the control of seizures and prevention of permanent brain damage.

Keyword

EEG; electrolyte; epilepsy; seizures; hyponatremia; hypernatremia; hypocalcemia

MeSH Terms

Brain
Diagnosis
Electroencephalography
Epilepsy
Humans
Hypernatremia
Hypocalcemia
Hyponatremia
Seizures*
Sensitivity and Specificity
Sodium
Sodium

Reference

1. Rose BD, Post TW. Clinical Physiology of Acid-base and Electrolyte Disorders. 5th ed. New York (NY): McGraw-Hill;2001.

2. Riggs JE. Neurologic manifestations of electrolyte disturbances. Neurol Clin. 2002; 20:227–239.

3. Castilla-Guerra L, del Carmen Fernández-Moreno M, López-Chozas JM, Fernández-Bolaños R. Electrolytes disturbances and seizures. Epilepsia. 2006; 47:1990–1998.

4. Kunze K. Metabolic encephalopathies. J Neurol. 2002; 249:1150–1159.

5. Schwartzkroin PA, Baraban SC, Hochman DW. Osmolarity, ionic flux, and changes in brain excitability. Epilepsy Res. 1998; 32:275–285.

6. Beghi E, Carpio A, Forsgren L, Hesdorffer DC, Malmgren K, Sander JW, et al. Recommendation for a definition of acute symptomatic seizure. Epilepsia. 2010; 51:671–675.

7. Victor M, Ropper AH, Adams RD. Adams and Victor's Principles of Neurology. 7th ed. New York (NY): McGraw-Hill;2011.

8. Browne TR, Holmes GL. Epilepsy. N Engl J Med. 2001; 344:1145–1151.

9. Oguni H. Diagnosis and treatment of epilepsy. Epilepsia. 2004; 45:Suppl 8. 13–16.

10. LaRoche SM, Helmers SL. Epilepsy in the elderly. Neurologist. 2003; 9:241–249.

11. DeLorenzo RJ, Towne AR, Pellock JM, Ko D. Status epilepticus in children, adults, and the elderly. Epilepsia. 1992; 33:Suppl 4. S15–S25.

12. Hirtz D, Ashwal S, Berg A, Bettis D, Camfield C, Camfield P, et al. Practice parameter: evaluating a first nonfebrile seizure in children: report of the quality standards subcommittee of the American Academy of Neurology, The Child Neurology Society, and The American Epilepsy Society. Neurology. 2000; 55:616–623.

13. Kaplan PW. The EEG in metabolic encephalopathy and coma. J Clin Neurophysiol. 2004; 21:307–318.

14. Smith SJ. EEG in neurological conditions other than epilepsy: when does it help, what does it add? J Neurol Neurosurg Psychiatry. 2005; 76:Suppl 2. ii8–ii12.

15. Lin CC. [EEG manifestations in metabolic encephalopathy]. Acta Neurol Taiwan. 2005; 14:151–161.

16. Adrogué HJ, Madias NE. Hypernatremia. N Engl J Med. 2000; 342:1493–1499.

17. Bhardwaj A. Neurological impact of vasopressin dysregulation and hyponatremia. Ann Neurol. 2006; 59:229–236.

18. Fraser CL, Arieff AI. Epidemiology, pathophysiology, and management of hyponatremic encephalopathy. Am J Med. 1997; 102:67–77.

19. Farrar HC, Chande VT, Fitzpatrick DF, Shema SJ. Hyponatremia as the cause of seizures in infants: a retrospective analysis of incidence, severity, and clinical predictors. Ann Emerg Med. 1995; 26:42–48.

20. Ayus JC, Wheeler JM, Arieff AI. Postoperative hyponatremic encephalopathy in menstruant women. Ann Intern Med. 1992; 117:891–897.

21. Nigro N, Winzeler B, Suter-Widmer I, Schuetz P, Arici B, Bally M, et al. Symptoms and characteristics of individuals with profound hyponatremia: a prospective multicenter observational study. J Am Geriatr Soc. 2015; 63:470–475.

22. Wójcik M, Janus D, Herman-Sucharska I, Starzyk JB. Generalized seizures as the first manifestation of multihormonal pituitary hormone deficiency causing normovolemic hyponatremia. Am J Case Rep. 2013; 14:507–510.

23. Guo J, Wang D, Zeng K, Xu G, Zhao Y. Generalized tonic-clonic seizures in adult patients following intravenous administration of desmopressin. Aging Clin Exp Res. 2013; 25:479–481.

24. Lucchini B, Simonetti GD, Ceschi A, Lava SA, Faré PB, Bianchetti MG. Severe signs of hyponatremia secondary to desmopressin treatment for enuresis: a systematic review. J Pediatr Urol. 2013; 9(6 Pt B):1049–1053.

25. Glover M, Clayton J. Thiazide-induced hyponatraemia: epidemiology and clues to pathogenesis. Cardiovasc Ther. 2012; 30:e219–e226.

26. Shubrata KS, Narayanaswamy JC, Viswanath B, Rudhran V, Chandrasekhar CR, Math SB. Sertraline-induced hyponatremia and seizures in old age. J Neuropsychiatry Clin Neurosci. 2012; 24:E47.

27. Flores G, Perez-Patrigeon S, Cobos-Ayala C, Vergara J. Severe symptomatic hyponatremia during citalopram therapy--a case report. BMC Nephrol. 2004; 5:2.

28. Fisher A, Davis M, Croft-Baker J, Purcell P, McLean A. Citalopram-induced severe hyponatraemia with coma and seizure. Case report with literature and spontaneous reports review. Adverse Drug React Toxicol Rev. 2002; 21:179–187.

29. Zifman E, Alehan F, Menascu S, Har-Gil M, Miller P, Saygi S, et al. Clinical characterization of gastroenteritis-related seizures in children: impact of fever and serum sodium levels. J Child Neurol. 2011; 26:1397–1400.

30. Halawa I, Andersson T, Tomson T. Hyponatremia and risk of seizures: a retrospective cross-sectional study. Epilepsia. 2011; 52:410–413.

31. Okazaki M, Ito M, Kato M. Effects of polydipsia-hyponatremia on seizures in patients with epilepsy. Psychiatry Clin Neurosci. 2007; 61:330–332.

32. Frizelle FA, Colls BM. Hyponatremia and seizures after bowel preparation: report of three cases. Dis Colon Rectum. 2005; 48:393–396.

33. Baeg MK, Park JM, Ko SH, Min GJ, Lee KJ, Yang JH, et al. Seizures due to hyponatremia following polyethylene glycol preparation; a report of two cases. Endoscopy. 2013; 45:Suppl 2 UCTN. E269–E270.

34. Hanna S, Tibby SM, Durward A, Murdoch IA. Incidence of hyponatraemia and hyponatraemic seizures in severe respiratory syncytial virus bronchiolitis. Acta Paediatr. 2003; 92:430–434.

35. Bruce RC, Kliegman RM. Hyponatremic seizures secondary to oral water intoxication in infancy: association with commercial bottled drinking water. Pediatrics. 1997; 100:E4.

36. Farrar HC, Chande VT, Fitzpatrick DF, Shema SJ. Hyponatremia as the cause of seizures in infants: a retrospective analysis of incidence, severity, and clinical predictors. Ann Emerg Med. 1995; 26:42–48.

37. Van Amelsvoort T, Bakshi R, Devaux CB, Schwabe S. Hyponatremia associated with carbamazepine and oxcarbazepine therapy: a review. Epilepsia. 1994; 35:181–188.

38. Johannessen AC, Nielsen OA. Hyponatremia induced by oxcarbazepine. Epilepsy Res. 1987; 1:155–156.

39. Seymour JF. Carbamazepine overdose. Features of 33 cases. Drug Saf. 1993; 8:81–88.

40. Kuz GM, Manssourian A. Carbamazepine-induced hyponatremia: assessment of risk factors. Ann Pharmacother. 2005; 39:1943–1946.

41. Gumbrevicius G, Sveikata A. [A case of severe hyponatremia in a patient suffering from epilepsy and using oxcarbazepine]. Medicina (Kaunas). 2006; 42:649–652.

42. Dong X, Leppik IE, White J, Rarick J. Hyponatremia from oxcarbazepine and carbamazepine. Neurology. 2005; 65:1976–1978.

43. Kelly BD, Hillery J. Hyponatremia during carbamazepine therapy in patients with intellectual disability. J Intellect Disabil Res. 2001; 45(Pt 2):152–156.

44. Kim YS, Kim DW, Jung KH, Lee ST, Kang BS, Byun JI, et al. Frequency of and risk factors for oxcarbazepine-induced severe and symptomatic hyponatremia. Seizure. 2014; 23:208–212.

45. Gupta DK, Bhoi SK, Kalita J, Misra UK. Hyponatremia following esclicarbazepine therapy. Seizure. 2015; 29:11–14.

46. Lin CH, Lu CH, Wang FJ, Tsai MH, Chang WN, Tsai NW, et al. Risk factors of oxcarbazepine-induced hyponatremia in patients with epilepsy. Clin Neuropharmacol. 2010; 33:293–296.

47. Smith PE. UK Oxcarbazepine Advisory Board. Clinical recommendations for oxcarbazepine. Seizure. 2001; 10:87–91.

48. Reddy VR, Moorthy SS. Electroencephalographic and clinical correlation of hyponatremia induced during transurethral resection of the prostate. Ann Neurol. 2001; 50:554–555.

49. Azuma H, Akechi T, Furukawa TA. Absence status associated with focal activity and polydipsia-induced hyponatremia. Neuropsychiatr Dis Treat. 2008; 4:495–498.

50. Luckey AE, Parsa CJ. Fluid and electrolytes in the aged. Arch Surg. 2003; 138:1055–1060.

51. Soupart A, Decaux G. Therapeutic recommendations for management of severe hyponatremia: current concepts on pathogenesis and prevention of neurologic complications. Clin Nephrol. 1996; 46:149–169.

52. Sarnaik AP, Meert K, Hackbarth R, Fleischmann L. Management of hyponatremic seizures in children with hypertonic saline: a safe and effective strategy. Crit Care Med. 1991; 19:758–762.

53. Adrogué HJ, Madias NE. Hyponatremia. N Engl J Med. 2000; 342:1581–1589.

54. Bringhurst FR, Demay MB, Kronenberg HM. Hormones and disorders of mineral metabolism. In : Wilson JD, Foster DW, Kronenberg HM, Larsen PR, editors. Williams Textbook of Endocrinology. 9th ed. Philadelphia (PA): WB Saunders;1998. p. 1155–1209.

55. Mrowka M, Knake S, Klinge H, Odin P, Rosenow F. Hypocalcemic generalised seizures as a manifestation of iatrogenic hypoparathyroidism months to years after thyroid surgery. Epileptic Disord. 2004; 6:85–87.

56. Messing RO, Simon RP. Seizures as a manifestation of systemic disease. Neurol Clin. 1986; 4:563–584.

57. Gupta MM. Medical emergencies associated with disorders of calcium homeostasis. J Assoc Physicians India. 1989; 37:629–631.

58. Modi S, Tripathi M, Saha S, Goswami R. Seizures in patients with idiopathic hypoparathyroidism: effect of antiepileptic drug withdrawal on recurrence of seizures and serum calcium control. Eur J Endocrinol. 2014; 170:777–783.

59. Levy-Shraga Y, Dallalzadeh K, Stern K, Paret G, Pinhas-Hamiel O. The many etiologies of neonatal hypocalcemic seizures. Pediatr Emerg Care. 2015; 31:197–201.

60. Kline CA, Esekogwu VI, Henderson SO, Newton KI. Non-convulsive status epilepticus in a patient with hypocalcemia. J Emerg Med. 1998; 16:715–718.

61. Basatemur E, Sutcliffe A. Incidence of hypocalcemic seizures due to vitamin D deficiency in children in the United Kingdom and Ireland. J Clin Endocrinol Metab. 2015; 100:E91–E95.

62. Chisti MJ, Salam MA, Ashraf H, Faruque AS, Bardhan PK, Shahid AS, et al. Prevalence, clinical predictors, and outcome of hypocalcaemia in severely-malnourished under-five children admitted to an urban hospital in Bangladesh: a case-control study. J Health Popul Nutr. 2014; 32:270–275.

63. Cesur Y, Yuca SA, Kaya A, Yilmaz C, Bay A. Vitamin D deficiency rickets in infants presenting with hypocalcaemic convulsions. West Indian Med J. 2013; 62:201–204.

64. Cheung EN, George SR, Andrade DM, Chow EW, Silversides CK, Bassett AS. Neonatal hypocalcemia, neonatal seizures, and intellectual disability in 22q11.2 deletion syndrome. Genet Med. 2014; 16:40–44.

65. Kehler L, Verma S, Krone R, Roper E. Vitamin D deficiency in children presenting to the emergency department: a growing concern. Vitamin D deficiency in Birmingham's children: presentation to the emergency department. Emerg Med J. 2013; 30:717–719.

66. Salama MM, El-Sakka AS. Hypocalcemic seizures in breastfed infants with rickets secondary to severe maternal vitamin D deficiency. Pak J Biol Sci. 2010; 13:437–442.

67. Mehrotra P, Marwaha RK, Aneja S, Seth A, Singla BM, Ashraf G, et al. Hypovitaminosis d and hypocalcemic seizures in infancy. Indian Pediatr. 2010; 47:581–586.

68. Tsourdi E, Rachner TD, Gruber M, Hamann C, Ziemssen T, Hofbauer LC. Seizures associated with zoledronic acid for osteoporosis. J Clin Endocrinol Metab. 2011; 96:1955–1959.

69. Ahmed MA, Martinez A, Mariam S, Whitehouse W. Chvostek's sign and hypocalcaemia in children with seizures. Seizure. 2004; 13:217–222.

70. Kossoff EH, Silvia MT, Maret A, Carakushansky M, Vining EP. Neonatal hypocalcemic seizures: case report and literature review. J Child Neurol. 2002; 17:236–239.

71. Bellazzini MA, Howes DS. Pediatric hypocalcemic seizures: a case of rickets. J Emerg Med. 2005; 28:161–164.

72. Marx SJ. Hyperparathyroid and hypoparathyroid disorders. N Engl J Med. 2000; 343:1863–1875.

73. Chen TH, Huang CC, Chang YY, Chen YF, Chen WH, Lai SL. Vasoconstriction as the etiology of hypercalcemia-induced seizures. Epilepsia. 2004; 45:551–554.

74. Juvarra G, Bettoni L, Olivieri MF, Bortone E, Cavatorta A. Hypercalcemic encephalopathy in the course of hyperthyroidism. Eur Neurol. 1985; 24:121–127.

75. Kaplan PW. Reversible hypercalcemic cerebral vasoconstriction with seizures and blindness: a paradigm for eclampsia? Clin Electroencephalogr. 1998; 29:120–123.

76. Euser AG, Cipolla MJ. Magnesium sulfate for the treatment of eclampsia: a brief review. Stroke. 2009; 40:1169–1175.

77. Kaplan PW. Neurologic aspects of eclampsia. Neurol Clin. 2004; 22:841–861.

78. Van Paesschen W, Bodian C, Maker H. Metabolic abnormalities and new-onset seizures in human immunodeficiency virus-seropositive patients. Epilepsia. 1995; 36:146–150.

79. Donaldson D, Trotman H, Barton M, Melbourne-Chambers R. Routine laboratory investigations in infants and children presenting with fever and seizures at the University Hospital of the West Indies. West Indian Med J. 2008; 57:369–372.

80. Wang AK, Sharma S, Kim P, Mrejen-Shakin K. Hypomagnesemia in the intensive care unit: Choosing your gastrointestinal prophylaxis, a case report and review of the literature. Indian J Crit Care Med. 2014; 18:456–460.

81. Gandhi NY, Sharif WK, Chadha S, Shakher J. A patient on long-term proton pump inhibitors develops sudden seizures and encephalopathy: an unusual presentation of hypomagnesaemia. Case Rep Gastrointest Med. 2012; 2012:632721.

82. Dubé L, Granry JC. The therapeutic use of magnesium in anesthesiology, intensive care and emergency medicine: a review. Can J Anaesth. 2003; 50:732–746.

83. Duley L. Magnesium sulphate regimens for women with eclampsia: messages from the Collaborative Eclampsia Trial. Br J Obstet Gynaecol. 1996; 103:103–105.

84. Visser NA, Braun KP, Leijten FS, van Nieuwenhuizen O, Wokke JH, van den Bergh WM. Magnesium treatment for patients with refractory status epilepticus due to POLG1-mutations. J Neurol. 2011; 258:218–222.

85. Robakis TK, Hirsch LJ. Literature review, case report, and expert discussion of prolonged refractory status epilepticus. Neurocrit Care. 2006; 4:35–46.

86. Gennari FJ. Hypokalemia. N Engl J Med. 1998; 339:451–458.

87. Shorvon SD. Introduction to the concept of symptomatic epilepsy. In : Shorvon SD, Andermann F, Guerrini R, editors. The Causes of Epilepsy: Common and Uncommon Causes in Adults and Children. Cambridge: Cambridge University Press;2011. p. 113–117.

88. Fisher RS, van Emde Boas W, Blume W, Elger C, Genton P, Lee P, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia. 2005; 46:470–472.

89. Hesdorffer DC, Benn EK, Cascino GD, Hauser WA. Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure. Epilepsia. 2009; 50:1102–1108.

90. Koppel BS. Treatment of acute and remote symptomatic seizures. Curr Treat Options Neurol. 2009; 11:231–241.